# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-037591
Filing Date
2025-04-30
Accepted
2025-04-30 16:01:34
Documents
181
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0238606-20f_adlai.htm iXBRL | 20-F | 3292306
2 | DESCRIPTION OF SECURITIES | ea023860601ex2-4_adlai.htm | EX-2.4 | 146968
3 | LIST OF PRINCIPAL SUBSIDIARIES OF THE REGISTRANT | ea023860601ex8-1_adlai.htm | EX-8.1 | 2941
4 | INSIDER TRADING POLICY | ea023860601ex11-2_adlai.htm | EX-11.2 | 47566
5 | CERTIFICATION | ea023860601ex12-1_adlai.htm | EX-12.1 | 12625
6 | CERTIFICATION | ea023860601ex12-2_adlai.htm | EX-12.2 | 12745
7 | CERTIFICATION | ea023860601ex13-1_adlai.htm | EX-13.1 | 5703
8 | CERTIFICATION | ea023860601ex13-2_adlai.htm | EX-13.2 | 5640
9 | CONSENT OF BDO CHINA SHU LUN PAN CERTIFIED PUBLIC ACCOUNTANTS LLP | ea023860601ex15-1_adlai.htm | EX-15.1 | 3969
15 | GRAPHIC | image_001.jpg | GRAPHIC | 27955
16 | GRAPHIC | image_002.jpg | GRAPHIC | 39601
17 | GRAPHIC | image_003.jpg | GRAPHIC | 12354
18 | GRAPHIC | image_004.jpg | GRAPHIC | 22375
19 | GRAPHIC | image_005.jpg | GRAPHIC | 25780
20 | GRAPHIC | image_006.jpg | GRAPHIC | 15602
21 | GRAPHIC | image_007.jpg | GRAPHIC | 15798
22 | GRAPHIC | image_008.jpg | GRAPHIC | 16185
23 | GRAPHIC | image_009.jpg | GRAPHIC | 62510
24 | GRAPHIC | image_010.jpg | GRAPHIC | 10673
25 | GRAPHIC | image_011.jpg | GRAPHIC | 33450
26 | GRAPHIC | image_012.jpg | GRAPHIC | 51374
27 | GRAPHIC | image_013.jpg | GRAPHIC | 33230
28 | GRAPHIC | image_014.jpg | GRAPHIC | 15337
29 | GRAPHIC | image_015.jpg | GRAPHIC | 23197
30 | GRAPHIC | image_016.jpg | GRAPHIC | 13053
31 | GRAPHIC | image_017.jpg | GRAPHIC | 20810
32 | GRAPHIC | image_018.jpg | GRAPHIC | 22401
33 | GRAPHIC | image_019.jpg | GRAPHIC | 23349
34 | GRAPHIC | image_020.jpg | GRAPHIC | 130254
35 | GRAPHIC | fin_001.jpg | GRAPHIC | 11844
36 | GRAPHIC | ex15-1_001.jpg | GRAPHIC | 40354
| Complete submission text file | 0001213900-25-037591.txt |  | 15619723

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL SCHEMA FILE | anl-20241231.xsd | EX-101.SCH | 166321
11 | XBRL CALCULATION FILE | anl-20241231_cal.xml | EX-101.CAL | 85714
12 | XBRL DEFINITION FILE | anl-20241231_def.xml | EX-101.DEF | 590130
13 | XBRL LABEL FILE | anl-20241231_lab.xml | EX-101.LAB | 995699
14 | XBRL PRESENTATION FILE | anl-20241231_pre.xml | EX-101.PRE | 615137
184 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0238606-20f_adlai_htm.xml | XML | 2031564

Mailing Address 685 U.S. HIGHWAY ONE, 2ND FLOOR NORTH BRUNSWICK NJ 08902
Business Address 685 U.S. HIGHWAY ONE, 2ND FLOOR NORTH BRUNSWICK NJ 08902 848-230-7430
Adlai Nortye Ltd. (Filer) CIK: 0001944552 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41773 | Film No.: 25894766
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)